Intelligence Platform
Patents
Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8809400
Method to ameliorate oxidative stress and improve working memory via pterostilbene adminis
granted patentUS 8802835
Proteins with repetitive bacterial-Ig-like (Big) domains present in leptospira species
granted patentUS 8796302
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted patentUS 8795674
Methods and compositions for modulating immune tolerance
granted patentUS 8795677
Treatment methods using an F1-V plague vaccine
granted patentUS 8795680
Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through
granted patentUS 8795964
GRM3 mutations and use thereof for the diagnosis and treatment of melanoma
granted patentUS 8796291
A3 adenosine receptor antagonists and partial agonists
granted patentUS 8790639
Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
granted patentUS 8790869
Renal cell carcinoma biomarkers
granted patentUS 8790635
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted patentUS 8791074
Mutated anthrax toxin protective antigen proteins that specifically target cells containin
granted patentUS 8785414
Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of SjΓΆgre
granted patentUS 8785421
Use of vitamin D in dairy mastitis treatment
granted patentUS 8785601
T cell receptors and related materials and methods of use
granted patentUS 8778847
Immunogenic peptides of influenza virus
granted patentUS 8778889
Antimicrobial decapeptide oral hygiene treatment
granted patentUS 8778671
Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine
granted patentUS 8779001
Stat3 inhibitors
granted patentUS 8779095
LAT adapter molecule for enhanced T-cell signaling and method of use
granted patentUS 8778354
Compositions and methods for modulating RSV infection and immunity
granted patentUS 8772256
Codon modified immunogenic compositions and methods of use
granted patentUS 8771706
Anti-RSV immunogens and methods of immunization
granted patentUS 8772238
Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
granted